SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615774-18-007805
Filing Date
2018-08-09
Accepted
2018-08-09 16:31:25
Documents
42
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q s111943_10q.htm 10-Q 511693
2 EXHIBIT 31,1 s111943_ex31-1.htm EX-31.1 10554
3 EXHIBIT 31,2 s111943_ex31-2.htm EX-31.2 10397
4 EXHIBIT 32.1 s111943_ex32-1.htm EX-32.1 7289
  Complete submission text file 0001615774-18-007805.txt   2778079

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE avxl-20180630.xml EX-101.INS 601998
6 XBRL SCHEMA FILE avxl-20180630.xsd EX-101.SCH 32359
7 XBRL CALCULATION FILE avxl-20180630_cal.xml EX-101.CAL 27948
8 XBRL DEFINITION FILE avxl-20180630_def.xml EX-101.DEF 102881
9 XBRL LABEL FILE avxl-20180630_lab.xml EX-101.LAB 247573
10 XBRL PRESENTATION FILE avxl-20180630_pre.xml EX-101.PRE 154254
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37606 | Film No.: 181005527
SIC: 8731 Services-Commercial Physical & Biological Research